Ren, Zhenggang

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study

Ren, Z., Xu, J., Bai, Y., Xu, A., Cang, S., Du, C., Li, Q., Lu, Y., Chen, Y., Guo, Y., et al. (2021) · The Lancet Oncology

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers

Cited by 1,124

Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study

Kudo, M., Ren, Z., Guo, Y., Han, G., Lin, H., Zheng, J., Ogasawara, S., Kim, J. H., Zhao, H., Li, C., et al. (2025) · The Lancet

Hepatocellular Carcinoma Treatment and PrognosisColorectal Cancer Treatments and Studies

Cited by 342

Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study

Wang, Z., Ren, Z., Chen, Y., Hu, J., Yang, G., Yu, L., Yang, X., Huang, A., Zhang, X., Zhou, S., et al. (2018) · Clinical Cancer Research

Hepatocellular Carcinoma Treatment and PrognosisHepatitis B Virus Studies

Cited by 318

Activation of Piezo1 contributes to matrix stiffness‐induced angiogenesis in hepatocellular carcinoma

Li, M., Zhang, X., Wang, M., Wang, Y., Qian, J., Xing, X., Wang, Z., You, Y., Guo, K., Chen, J., et al. (2022) · Cancer Communications

Cellular Mechanics and InteractionsAngiogenesis and VEGF in Cancer

Cited by 181

Matrix stiffness‐mediated effects on macrophages polarization and their LOXL2 expression

Xing, X., Wang, Y., Zhang, X., Gao, X., Li, M., Wu, S., Zhao, Y., Chen, J., Gao, D., Chen, R., et al. (2021) · The FEBS Journal

Cellular Mechanics and InteractionsImmune cells in cancer

Cited by 92

A synergistic regulation works in matrix stiffness-driven invadopodia formation in HCC

Zhang, X., Zhao, Y., Li, M., Wang, M., Qian, J., Wang, Z., Wang, Y., Wang, F., Guo, K., Gao, D., et al. (2024) · Cancer Letters

Cellular Mechanics and InteractionsProtease and Inhibitor Mechanisms

Cited by 35

Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection Exhibited Favorable Survival from Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Du, Q., Yuan, J., & Ren, Z. (2024) · Liver Cancer

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers

Cited by 20